Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
Cancer Cell · 2024-11 · 42 (11) · 1919-1935.e9
DOI: 10.1016/j.ccell.2024.09.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-11. Verfasst von Rei Kudo und 27 weiteren Autor:innen. Beteiligte Einrichtung: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Department of Surgery, The Jikei Univ…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Breast Cancer Research Foundation, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA; Department of Surgery, The Jikei University School of Medicine, Tokyo 1058461, Japan.
- Breast Medicine Service, Department of Medicine, MSK, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA.
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSK), New York, NY 10065, USA.
- Department of Medicine, MSK, New York, NY 10065, USA; Department of Epidemiology and Biostatistics, MSK, New York, NY 10065, USA.
- Tempus AI, Boston, MA 02110, USA.
- Department of Pathology and Laboratory Medicine, MSK, New York, NY 10065, USA.
Förderung
- NCI NIH HHS
- Breast Cancer Research Foundation
- Foundation for the National Institutes of Health
Zitieren
APA
Kudo, R., Safonov, A., Jones, C., Moiso, E., Dry, J. R., Shao, H., Nag, S., da Silva, E. M., Yildirim, S. Y., Li, Q., O'Connell, E., Patel, P., Will, M., Fushimi, A., Benitez, M., Bradic, M., Fan, L., Nakshatri, H., Sudhan, D. R., …, & Chandarlapaty, S. (2024). Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer Cell, 42(11), 1919-1935.e9. https://doi.org/10.1016/j.ccell.2024.09.009
Vancouver
Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, et al. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion. Cancer Cell. 2024;42(11):1919-1935.e9. doi:10.1016/j.ccell.2024.09.009
BibTeX
@article{Kudo2024,
author = {Kudo, Rei and Safonov, Anton and Jones, Catherine and Moiso, Enrico and Dry, Jonathan R and Shao, Hong and Nag, Sharanya and da Silva, Edaise M and Yildirim, Selma Yeni and Li, Qing and O'Connell, Elizabeth and Patel, Payal and Will, Marie and Fushimi, Atsushi and Benitez, Marimar and Bradic, Martina and Fan, Li and Nakshatri, Harikrishna and Sudhan, Dhivya R and Denz, Christopher R and Huerga Sanchez, Iker and Reis-Filho, Jorge S and Goel, Shom and Koff, Andrew and Weigelt, Britta and Khan, Qamar J and Razavi, Pedram and Chandarlapaty, Sarat},
title = {Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {11},
pages = {1919--1935.e9},
doi = {10.1016/j.ccell.2024.09.009}
}
EUVIMED